摘要
目的:分析持续皮下注射胰岛素对2型糖尿病(T2DM)合并肺部感染患者的临床疗效。方法:将我院2010年6月至2013年6月收治的86例2型糖尿病合并肺部感染患者随机分为2组,分别采用胰岛素泵持续皮下注射(治疗组)和多次皮下注射胰岛素(对照组),观察患者血糖指标、血糖达标时间、低血糖发生率及肺部感染治愈率情况。结果:治疗后,两组患者的血糖均得到控制,治疗组的血糖指标变化、血糖达标时间及住院时间均优于对照组,差异均有统计学意义(均P<0.05)。治疗组的低血糖发生率明显低于对照组,而肺部感染治愈率显著高于对照组,差异均有统计学意义(均P<0.05)。结论:胰岛素泵持续皮下胰岛素注射在治疗2型糖尿病合并肺部感染患者中使用,血糖达标迅速,降低低血糖发生率,缩短住院时间,提高感染治愈率,临床效果好。
Objective: To analyze the clinical effect of continuous subcutaneous insulin infusion treatment of type 2 diabetes with pulmonary infection. Methods: 86 cases of type 2 diabetes complicated with pulmonary infection from June 2010 to June 2013 in our hospital were randomly divided into two groups, namely treatment group and control group. The treatment group were treated by continuous subcutaneous insulin infusion, and the control group were given hypodermic injection repeatedly. The patients' blood glucose index, time to reach normal level of blood glucose, the incidence of hypoglycemia and the clinical effect were analyzed. Results: Both of the two groups reached the target level of blood glucose after treatment, but the mean time of blood sugar controlling and the duration of hospital stays was shorter in the treatment group than in the control group, the difference was statistically significant (all P〈0.05). The incidence of hypoglycemia and the curative ratio of pulmonary infection in the treatment group was significantly lower than in the control group, and the difference was statistically significant (all P〈0.05). Conclusion: Continuous subcutaneous insulin infusion treatment is effective in patients of type 2 diabetes with pulmonary infection, it can effectively reduce the incidence of hypoglycemia, shorten the hospital stays and increase the curative ratio of pulmonary infection, thus is worth clinical promotion.
出处
《现代生物医学进展》
CAS
2015年第2期284-286,307,共4页
Progress in Modern Biomedicine
关键词
2型糖尿病
肺部感染
胰岛素
Type 2 diabetes
Pulmonary infection
Insulin